FDA Authorizes First Device to Continuously Monitor Glucose and Ketones
The U.S. Food and Drug Administration has authorized the first wearable device that continuously monitors both ketone levels and blood sugar. The Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System received approval for use by individuals aged two years and older living with diabetes.
Advertisement
The U.S. Food and Drug Administration has authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System. This authorization marks the first time a wearable device has gained approval to continuously monitor both ketone levels and blood sugar.
Individuals aged two years and older who live with diabetes can now use this system. The device provides continuous data on these two biomarkers.
Related Topics
Article Ratings
How do you feel about this story?
National Desk
Sign in to follow this author from their profile.
Discussion (0)
Join the Conversation
Join the conversation
Sign in to share your thoughts, reply to readers, and like comments.
No comments yet. Be the first to comment!